锡诺巴酸盐的有效性和耐受性:一个单一中心的经验
Christopher Saouda1, Omar Nofal1, Yamane Makke1
1George Washington University, Department of Neurology, Washington, DC, USA.
Epilepsy research
|December 21, 2024
概括
雪诺巴 (CNB) 有效治疗耐药性 (MRE),超过三分之一的患者实现了无发作. 这项研究突出了CNB的重点.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 临床药理学 临床药理学
背景情况:
- 耐药性 (MRE) 影响了对两种或两种以上抗发作药物 (ASM) 无反应的患者.
- 在初始治疗失败后,ASM的疗效显著下降.
- 塞诺巴酸 (CNB) 显示出改善MRE中的控制的前景.
研究的目的:
- 评估Cenobamate (CNB) 在患有MRE的成年患者中的实际有效性和耐受性.
- 报告单一中心发现的关于CNB对控制和患者结果的影响.
主要方法:
- 对104名接受CNB治疗的成人MRE患者进行了回顾性研究 (2020-2023年).
- 从乔治华盛顿大学 (GWU) 的电子病历中收集的数据.
- 统计分析评估了CNB对扣押控制和耐受性的影响.
主要成果:
- 34.6%的MRE患者实现了至少三个月的发作自由.
- 抓获自由的平均持续时间是11个月.
- 111名患者被纳入了耐受性分析.
结论:
- 雪诺巴 (CNB) 在大量MRE患者队列中表现出显著的抗发作活性.
- 很大一部分患有MRE的患者通过使用CNB实现了无性发作,即使在之前的ASM失败后也是如此.
- 对于耐火性患者来说,CNB提供了一个可行的治疗选择.
更多相关视频
相关概念视频
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Sedatives and Hypnotics Drugs: Miscellaneous Agents
145
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
145
Antiepileptic Drugs: Potassium Channel Activators
143
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
143
Time Course of Drug Effect
1.9K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.9K


